Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor-Rich Plasma Intraovarian Growth in Low Ovarian Reserve
2024-514444-87-00Phase 2Authorised
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Oct 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of PRGF-Endoret in Diminished Ovarian Reserve (DOR) and female infertility, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Planned start Oct 2024; status: authorised.
02
Drugs
PRGF-Endoret
03
Conditions
Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on 2024-514444-87-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514444-87-00.